The HCPLive Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.
October 24th 2024
Aquestive Therapeutics plans to submit an NDA for Anaphylm in Q1 2025 based on topline results from the Oral Allergy Syndrome challenge study.
Revolo Readying Data on Allergen Sensitivity Drug
The treatment is a first-in-class peptide derived from mTB Chaperonin 60.1 that is often involved in resetting the immune system. The treatment is being evaluated in patients with eosinophilic esophagitis and allergen sensitivity.
Strengths, Limitations Found in Penicillin Allergy Machine Learning Prediction Model
Data presented at the AAAAI annual meeting showed that machine learning models had a high accuracy rate in penicillin allergy prediction, though researchers concluded that more data is needed before adoption.
Arman Kalamkarian, MD, on Chronic Allergy Symptom Relief with Intranasal Cleansing
March 1st 2023A study presented at the AAAAI 2023 Annual Meeting shows over 80% of the 20 patients with chronic allergy symptoms report significant improvement in their allergy symptoms after 2 weeks of intranasal cleansing with NasoClenz.
Symptoms of Anaphylaxis Have Greater Cardiovascular Involvement, Differ from Older Adults
New data presented at the 2023 AAAAI Annual Meeting indicated that infants with anaphylaxis had different symptoms from those who were older, with greater involvement in other areas.